Cutting Edge: Essential Role of Hypoxia Inducible Factor-1 in Development of Lipopolysaccharide-Induced Sepsis

Division of Biological Sciences, School of Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
The Journal of Immunology (Impact Factor: 4.92). 07/2007; 178(12):7516-9. DOI: 10.4049/jimmunol.178.12.7516
Source: PubMed


Sepsis, the leading cause of death in intensive care units, reflects a detrimental host response to infection in which bacteria or LPS act as potent activators of immune cells, including monocytes and macrophages. In this report, we show that LPS raises the level of the transcriptional regulator hypoxia-inducible factor-1alpha (HIF-1alpha) in macrophages, increasing HIF-1alpha and decreasing prolyl hydroxylase mRNA production in a TLR4-dependent fashion. Using murine conditional gene targeting of HIF-1alpha in the myeloid lineage, we demonstrate that HIF-1alpha is a critical determinant of the sepsis phenotype. HIF-1alpha promotes the production of inflammatory cytokines, including TNF-alpha, IL-1, IL-4, IL-6, and IL-12, that reach harmful levels in the host during early sepsis. HIF-1alpha deletion in macrophages is protective against LPS-induced mortality and blocks the development of clinical markers including hypotension and hypothermia. Inhibition of HIF-1alpha activity may thus represent a novel therapeutic target for LPS-induced sepsis.

Download full-text


Available from: Randall S Johnson, Mar 31, 2014
  • Source
    • "Murine myeloid specific knockouts of both HIF-1α and HIF-2α show distinct activities in regulating the immune response. Mice lacking myeloid HIF-1α show reduced migration and invasion of macrophages, limited acute inflammation, and inhibition of bactericidal activity (28–30). Mice lacking myeloid HIF-2α are resistant to endotoxemia and inflammatory lesions (31). "
    [Show abstract] [Hide abstract]
    ABSTRACT: It is widely accepted that the tumor microenvironment (TUMIC) plays a major role in cancer and is indispensable for tumor progression. The TUMIC involves many "players" going well beyond the malignant-transformed cells, including stromal, immune, and endothelial cells (ECs). The non-malignant cells can acquire tumor-promoting functions during carcinogenesis. In particular, these cells can "orchestrate" the "symphony" of the angiogenic switch, permitting the creation of new blood vessels that allows rapid expansion and progression toward malignancy. Considerable attention within the context of tumor angiogenesis should focus not only on the ECs, representing a fundamental unit, but also on immune cells and on the inflammatory tumor infiltrate. Immune cells infiltrating tumors typically show a tumor-induced polarization associated with attenuation of anti-tumor functions and generation of pro-tumor activities, among these angiogenesis. Here, we propose a scenario suggesting that the angiogenic switch is an immune switch arising from the pro-angiogenic polarization of immune cells. This view links immunity, inflammation, and angiogenesis to tumor progression. Here, we review the data in the literature and seek to identify the "conductors" of this "orchestra." We also suggest that interrupting the immune → inflammation → angiogenesis → tumor progression process can delay or prevent tumor insurgence and malignant disease.
    Frontiers in Oncology 07/2014; 4:131. DOI:10.3389/fonc.2014.00131
  • Source
    • "Moreover, alteration in the gingival blood flow due to the reduced erythrocyte count might decrease the oxygen content in the gingival tissues [12]. Hypoxia produced as a result, induced the activation of the transcription factor hypoxia-inducible factor-1, triggering the expression of proinflammatory genes [37] and increased production of mitochondrial ROS, which activate the endothelial secretion of leukocyte adhesion receptors, thereby promoting the inflammatory response [38]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Both chronic periodontitis (CP) and iron deficiency anemia (IDA) induce oxidative stress in the body and cause an imbalance between reactive oxygen species and antioxidants, such as superoxide dismutase (SOD). This study explored the SOD enzyme activity of saliva and serum in CP patients with and without IDA and analyzed the impact of IDA on CP. A total of 82 patients were divided into four groups: control group (CG, 22), periodontally healthy IDA patients (IDA-PH, 20), CP patients (CP, 20), and IDA patients with CP (IDA-CP, 20). After clinical measurements and samplings, serum and salivary SOD levels were determined using an SOD assay kit. IDA-CP patients exhibited a higher gingival index, bleeding on probing, probing pocket depth, and percentage (%) of sites with a clinical attachment loss (CAL) of ≥6 mm (P<0.008) than CP patients. The mean salivary and serum SOD levels were significantly lower in the IDA-PH, CP, and IDA-CP patients than in the CG group (P<0.008). A significant positive correlation between salivary and serum SOD activity was observed in IDA (P<0.05). Furthermore, serum and salivary SOD levels were significantly and negatively correlated with all periodontal parameters including the percentage of sites with CAL of 4-5 and ≥6 mm (P<0.05) except the significant correlation between salivary SOD activity and mean CAL and the percentage of sites with CAL of 4-5 mm (P>0.05) in these patients. Within the limits of this study, it may be suggested that IDA patients with chronic periodontitis have more periodontal breakdowns than patients with chronic periodontitis. Serum and salivary SOD activity levels were lower in the IDA-PH, CP and IDA-CP groups than in the CG. Iron deficiency anemia influenced the serum SOD activity but did not seem to affect the salivary SOD activity in these patients.
    Journal of periodontal & implant science 04/2014; 44(2):57-64. DOI:10.5051/jpis.2014.44.2.57 · 1.15 Impact Factor
  • Source
    • "HIF-1␣ is a transcriptional factor that upregulates the expression of various genes in response to hypoxia, inflammation, and oxidative stress (Heyman et al. 2011). Lipopolysaccharides have been demonstrated to induce the expression of HIF-1␣ protein and HIF-1 dependent gene, even in the absence of hypoxia, in macrophages and the hepatic tissue of rats (Peyssonnaux et al. 2007; Kan et al. 2008). In animals subjected to LPS treatment, a significant increase in hepatic HIF-1␣ levels was probably due to LPS-induced tissue hypoxia and (or) the secretion of proinflammatory cytokines . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Plasma levels of asymmetric dimethylarginine (ADMA) are known to be elevated under pathological conditions, but reports on intracellular ADMA levels are scarce. In this study, we investigated whether lipopolysaccharide (LPS)-induced endotoxemia alters the intra- and extra-cellular partition of l-arginine and ADMA. The effect of H2S pretreatment was also researched. Wistar rats were given sodium hydrogen sulfide (NaHS, 1 mg·(kg body mass)(-1)) one hour before the LPS injections (20 mg·kg(-1)). Six hours after the LPS treatment, the animals were sacrificed. Myeloperoxidase (MPO) and dimethylarginine dimethylaminohydrolase (DDAH) activities and levels of hypoxia-inducible factor (HIF)-1α were measured in the liver. ADMA and arginine levels were determined using HPLC. LPS injection caused liver injury, as evidenced by the activities of alanine transaminase, aspartate transaminase, and arginase. LPS increased l-arginine content and decreased DDAH activity in the rat liver. MPO activity and HIF-1α levels indicated inflammation and hypoxia. Despite the accumulation of ADMA in the plasma, the level remained unchanged in the liver. NaHS pretreatment restored both the DDAH activity and intracellular l-arginine levels. It is concluded that increased H2S generation has a potency to restore hepatic l-arginine levels and ADMA handling in endotoxemia. Extra- and intra-cellular partitions of ADMA seem to depend on transport proteins as well as the DDAH activity.
    Canadian Journal of Physiology and Pharmacology 12/2013; 91(12):1071-5. DOI:10.1139/cjpp-2013-0114 · 1.77 Impact Factor
Show more